Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Neuron. 2012 Sep 6;75(5):904-15. doi: 10.1016/j.neuron.2012.07.010.

    Autism-associated promoter variant in MET impacts functional and structural brain networks.

    Source

    Ahmanson-Lovelace Brain Mapping Center, University of California, Los Angeles, Los Angeles, CA 90095-7085, USA.

    Abstract

    As genes that confer increased risk for autism spectrum disorder (ASD) are identified, a crucial next step is to determine how these risk factors impact brain structure and function and contribute to disorder heterogeneity. With three converging lines of evidence, we show that a common, functional ASD risk variant in the Met Receptor Tyrosine Kinase (MET) gene is a potent modulator of key social brain circuitry in children and adolescents with and without ASD. MET risk genotype predicted atypical fMRI activation and deactivation patterns to social stimuli (i.e., emotional faces), as well as reduced functional and structural connectivity in temporo-parietal regions known to have high MET expression, particularly within the default mode network. Notably, these effects were more pronounced in individuals with ASD. These findings highlight how genetic stratification may reduce heterogeneity and help elucidate the biological basis of complex neuropsychiatric disorders such as ASD.

    Copyright © 2012 Elsevier Inc. All rights reserved.

    PMID:
    22958829
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3454529
    [Available on 2013/9/6]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk